GA
Gopalakrishnan Arun
About Gopalakrishnan Arun
Data last updated:
Gopalakrishnan Arun is a Director at Asterima Pharmaceuticals Private Limited (since 2021). The company operates in Pharma. Asterima Pharmaceuticals Private Limited reported revenue of ₹1.97 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Asterima Pharmaceuticals Private Limited U24230MH2016PTC280401 | Director | 01 Oct 2021 | 2016 | ₹1.97 Cr (FY 2025) | Active |
Board colleagues of Gopalakrishnan Arun
| Name | DIN | Company | Designation |
|---|---|---|---|
| Girish | 09406151 | Asterima Pharmaceuticals Private Limited | Director |
| Mandeep Warrier | 09231020 | Asterima Pharmaceuticals Private Limited | Director |
| Saneesh Methanath | 07486244 | Asterima Pharmaceuticals Private Limited | Managing Director |
| Soumya Tomy | 09838202 | Asterima Pharmaceuticals Private Limited | Director |
| Sumesh Methanath | 07486264 | Asterima Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Gopalakrishnan Arun
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gopalakrishnan Arun
Gopalakrishnan Arun currently holds 1 directorship: Asterima Pharmaceuticals Private Limited (Director, since 01 Oct 2021, revenue ₹1.97 Cr (FY 2025)).
Gopalakrishnan Arun was first appointed on 01 Oct 2021 as Director at Asterima Pharmaceuticals Private Limited.
The current boards of Gopalakrishnan Arun's companies include Girish (Asterima Pharmaceuticals Private Limited), Mandeep Warrier (Asterima Pharmaceuticals Private Limited), Saneesh Methanath (Asterima Pharmaceuticals Private Limited), Soumya Tomy (Asterima Pharmaceuticals Private Limited), Sumesh Methanath (Asterima Pharmaceuticals Private Limited).